Valuation: Evogene Ltd.

Market Cap 5.28M 0 4.59M 4.27M 3.92M 7.41M 504M 7.52M 50.37M 19.77M 251M 19.83M 19.4M 842M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 5.28M 0 4.59M 4.27M 3.92M 7.41M 504M 7.52M 50.37M 19.77M 251M 19.83M 19.4M 842M EV / Sales 2026 *
3.56x
EV / Sales 2027 * 2.03x
Free-Float
82.39%
Yield 2026 *
-
Yield 2027 * -
1 day+0.91%
1 week-10.37%
1 month+21.87%
3 months-31.32%
6 months-51.16%
Current year-48.27%
1 week 151.2
Extreme 151.2
181
1 month 122.7
Extreme 122.7
194.1
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,940
5 years 115.1
Extreme 115.1
10,430
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 2004-11-30
Corporate Officer/Principal - -
Corporate Officer/Principal - 2021-12-31
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 2010-06-02
Chairman 60 2021-05-31
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Other

Executive/Senior Manager

40,000 0.4588%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-10.37%-62.12%-95.94% 5.24M
-1.40%+2.59%-1.71%+11.28% 49.37B
-2.41%-0.90%+403.17%+614.40% 40.85B
-1.16%+12.96%+26.45%+5.03% 39.14B
-1.88%-3.03%+4.94%+47.52% 35.81B
-1.74%+5.12%+9.58%+46.02% 30.5B
-2.85%-3.92% - - 16.55B
-0.21%-4.04%+35.09%+127.95% 16.14B
-0.64%+2.65%+1.25%+8.92% 13.71B
-1.19%-1.32%-3.32%-34.94% 12.77B
Average -1.26%+0.91%+45.92%+81.14% 25.49B
Weighted average by Cap. -1.60%+3.18%+77.34%+128.83%

Financials

2026 *2027 *
Net sales 1.48M 0 1.29M 1.2M 1.1M 2.08M 142M 2.11M 14.15M 5.55M 70.53M 5.57M 5.45M 236M 2.6M 0 2.26M 2.1M 1.93M 3.65M 248M 3.7M 24.8M 9.73M 124M 9.76M 9.55M 414M
Net income -16.69M -0 -14.51M -13.5M -12.4M -23.41M -1.59B -23.77M -159M -62.46M -793M -62.67M -61.29M -2.66B -13.92M -0 -12.1M -11.26M -10.34M -19.52M -1.33B -19.82M -133M -52.09M -661M -52.26M -51.11M -2.22B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
26-07-31 ILA 155.50 +0.91% 280
26-07-30 ILA 154.10 -2.78% 37,943
26-07-29 ILA 158.50 -1.00% 50,045
26-07-28 ILA 160.10 -6.15% 80,169
26-07-27 ILA 170.60 -1.67% 95,233

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock